Kunda Uma Maheswara
Rao
a,
Soora Harinath
Jayaprakash
a,
Sandip Kumar
Nayak
b and
Cirandur Suresh
Reddy
*a
aDepartment of Chemistry, Sri Venkateswara University, Tirupati-517 502, A.P., India. E-mail: csrsvu@gmail.com; Fax: +91-877 2289555; Tel: +91-9849694958
bBio-Organic Division, BARC, Mumbai, India
First published on 10th October 2011
A simple and highly efficient protocol for C–P bond formation under catalyst free conditions at an ambient temperature is reported by using polyethylene glycol in water as an efficient recyclable medium without using any organic co-solvent or additive.
A number of synthetic methods for α-amino phosphonates have been developed.6 The Kabachnik–Fields and Pudovik reactions are the most general, straightforward and widely applied methods for construction of C–P bonds.7 Of these, the nucleophilic addition of phosphites to imines, catalyzed by a base or an acid, is the most convenient route. Lewis acids such as SnCl4,8a BF3·OEt2,8b and ZnCl28c have been used for this transformation. However, these reactions could not be carried out in a one-pot single step operation with a carbonyl compound, an amine and a dialkyl phosphite because the amine and water formed during imine formation decompose or deactivate the Lewis acid.8d This drawback has been partly overcome in some recent methods using lanthanide triflates/MgSO4,9a InCl3,9b TaCl5–SiO2,9c bismuth nitrate pentahydrate,9d MgClO4,9e TiO2,9f Amberlite-IR 120,9g sulfamic acid,9h H3PW12O40,9i trimethylanilinium chloride,9j lithium perchlorate,9k Amberlyst-15,9l and ZrOCl2·8H2O.9m However, the continual search for a new and greener synthetic protocol that is simple, efficient and cost effective remains an ever-challenging objective. In continuation of our program on the development of novel organic synthetic methodologies,10 we have investigated the synthesis of α-aminophosphonate and α-hydroxyphosphonate derivatives by using polyethylene glycol-600 (PEG-600) in water as a recyclable medium without adding any organic solvent and catalyst.
In the recent years, PEG, a biologically acceptable polymer, emerged as a powerful phase transfer catalyst and performs many useful organic transformations under mild reaction conditions. Moreover, PEG and its monomethyl ethers are inexpensive, thermally stable, recoverable, and are proved to be non-toxic phase-transfer catalysts. The PEG has hitherto not been widely used as a solvent medium but has been used as a support for various transformations.11 The use of water as a reaction medium has received considerable attention in the context of green chemistry, because it is a cheap, safe and environmentally benign medium.12 This background prompted us to use PEG in water as reaction medium and surprisingly it worked successfully even without any catalyst.
An efficient C–P bond formation by using PEG in water in the absence of a catalyst is not yet reported. This report on the C–P bond formation using PEG in water at an ambient temperature is a successful endeavor that realised this goal.
![[C with combining low line]](https://www.rsc.org/images/entities/char_0043_0332.gif)
N carbon through hydrogen bonding of hydroxyl oxygen with the imine nitrogen and water plays the role of a proton source. After this success, several aldehydes and diethyl/dimethyl phosphite were reacted using PEG in water. The results are summarized in Table 3. In all the cases, the three component coupling proceeded smoothly and the corresponding α-amino phosphonate was isolated. In these experiments, the catalyst was isolated by cooling the reaction mixture in a dry ice–acetone bath to precipitate the PEG and extracted with ether. The ether extract was dried over MgSO4 and could be reloaded with fresh reagents for further runs, thus, recyclization of the PEG is possible without significant loss of activity (Table 3, entry 4a).13 Surprisingly, from the reaction of aldehydes (2a–l) and dialkyl phosphite (3) in the presence of an amine (1) (Scheme 1), no α-hydroxyphosphonate formation is observed.14 The examples studied included electron-rich aromatic aldehydes (entries 4e, 4f, 4g, 4h), electron deficient aromatic aldehydes (entries 4a, 4b), heterocyclic aldehydes (entries 4c, 4d, 4i, 4j) and aliphatic aldehydes (entries 4k, 4l). All of them gave α-amino phosphonates in good yields at room temperature only. Ketones do not react under these conditions.
| Entry | R1 | R2 | Time/min | Yield (%) |
|---|---|---|---|---|
| a Isolated yields after recycling of catalysts. | ||||
| 4a | 3-NO2–C6H4 | Et | 65 | 93 (90, 87, 88, 89)a |
| 4b | 3-NO2–C6H4 | Me | 72 | 89 |
| 4c | 2-Imidazolyl | Et | 80 | 89 |
| 4d | 2-Imidazolyl | Me | 85 | 82 |
| 4e | 4-N(CH3)2–C6H4 | Et | 75 | 91 |
| 4f | 4-N(CH3)2–C6H4 | Me | 83 | 86 |
| 4g | 4-OH–C6H4 | Et | 83 | 85 |
| 4h | 4-OH–C6H4 | Me | 90 | 79 |
| 4i | 3-Indolyl | Et | 74 | 92 |
| 4j | 3-Indolyl | Me | 78 | 86 |
| 4k | C6H5CH2CH2– | Et | 87 | 89 |
| 4l | CH3–CH–CH3 | Et | 90 | 84 |
![]() | ||
| Scheme 1 | ||
In assessing the catalytic activity of PEG in water, we extended the reaction and studied the addition of diethyl phosphite to aldehydes. This reaction proceeds smoothly and gave the corresponding α-hydroxy phosphonates in excellent yields. In recent times, α-hydroxyphosphonates are drawing increased attention due to their enzyme inhibitory bioactivity towards rennin,15a enolpyruvylshikimate-3-phosphate synthase,15b farnesyl protein transferase,15c human immunodeficiency virus protease and polymerase.15d They also exhibit anti-virus15e and anti-cancer activity.15f Furthermore, α-hydroxy phosphonates are useful precursors for the preparation of a variety of α-functionalized phosphonates, such as α-amino,16a α-keto,16b α-halo16c and α-acetoxyphosphonates16d and their extended derivatives. The available methods for the synthesis of α-hydroxyphosphonates involve the nucleophilic addition of di or trialkylphosphite to different carbonyl compounds in the presence of various catalysts, such as, enzymes,17a alkaloids,17b phosphoric acids,17c Lewis acids,17d alumina,17e SALEN,17f BINOL,17g alumina/potassium fluoride,17h NH4VO317i and polymer/solid supported base.17j When we tried to improve the yields, none of them was satisfactory. Hence, there arose still a need to search for an efficient method for their preparation. Herein, we report our results for the preparation of α-hydroxy phosphonates from aldehydes and diethyl phosphite using PEG in water at room temperature (Scheme 2).
![]() | ||
| Scheme 2 | ||
Reaction of 3-nitro benzaldehyde with diethyl phosphite in the absence of PEG afforded low (<20%) yield of diethyl 1-hydroxy-3-nitrophenylmethylphosphonate. The same reaction when performed in the presence of PEG in water at room temperature resulted in the formation of the desired products in high yields (Table 4). Further, no byproduct formation occurred in these reactions.
| Entry | R3 | Time/min | Yield (%) |
|---|---|---|---|
| 7a | 3-NO2–C6H4 | 90 | 92 |
| 7b | 4-F–C6H4 | 122 | 83 |
| 7c | 2-Imidazolyl | 95 | 88 |
| 7d | 3-Indolyl | 115 | 86 |
| 7e | 2,4-Cl–C6H3 | 130 | 90 |
| 7f | 4-Cl–C6H4 | 135 | 83 |
| 7g | 4-OH–C6H4 | 110 | 86 |
| 7h | 4-Isopropyl–C6H4 | 120 | 89 |
| 7i | 4-(NCH3)2–C6H4 | 95 | 84 |
| 7j | 3,5-OMe–C6H3 | 130 | 85 |
When this reaction was performed in organic solvents such as ethanol, MeCN, CH2Cl2, CHCl3, THF, dioxane, low (<20%) yields of the α-hydroxy phosphonates were obtained. Ketones and triethyl phosphite did not react under these conditions.
:
4) as an eluent. The recovered PEG has been reused.13
:
6) as an eluent. The recovered PEG has been reused.12
O), 752 (P-C); 1H NMR (DMSO-d6, 500 MHz): δ 7.65–7.82 (m, 4Ar–H), 6.23 (s, isoxazole H), 5.54 (brs, NH), 4.89 (d, JP-C = 7.2 Hz, P-CH), 3.81–4.19 (m, 4H, P(O)CH2CH3), 1.94 (s, -CH3), 1.21 (t, 6H, 3J = 7.3 Hz, P(O)CH2CH3); 13C NMR (DMSO-d6, 75.4 MHz): δ 161.21 (C-5′), 154.16 (C-2′), 141.13 (C-1), 133.86 (C-3), 129.37 (C-6), 122.36 (C-5), 121.72 (C-2), 115.23 (C-4), 113.5 (C-4′), 64.5 (d, 2JP-C = 7.6 Hz, P(O)CH2CH3), 45.9 (P-C), 16.9 (d, 3JP-C = 5.9 Hz, P(O)CH2CH3), 15.2 (-CH3); 31P NMR (DMSO-d6, 121.4 MHz): δ 20.56; ESI-MS: 369.25; anal. calcd for C15H20N3O6P (369): C, 48.78; H, 5.46; N, 11.38%. Found: C, 48.72; H, 5.43; N, 11.35%.
O), 758 (P–C); 1H NMR (DMSO-d6, 500 MHz): δ 7.62–7.81 (m, 4Ar-H), 6.26 (s, isoxazole H), 5.49 (brs, NH), 4.78 (d, JP-C = 7.2 Hz, P-CH), 3.55 (d, 3JP-H= 10.5 Hz, P-OCH3), 3.73 (d, 3JP-H= 10.9 Hz, P-OCH3), 1.92 (s, -CH3); 31P NMR (DMSO-d6, 121.4 MHz): δ 24.80; ESI-MS: 341.02; anal. calcd for C13H16N3O6P (341): C, 45.75; H, 4.73; N, 12.31%. Found: C, 45.69; H, 4.69; N, 12.25%.
O), 761 (P-C); 1H NMR (DMSO-d6, 500 MHz): δ 5.90 (s, 1H, NH), 7.45–7.65 (m, 3Ar-H), 5.60 (d, JP-C = 10.8 Hz, P-CH), 3.81–4.09 (m, 4H, P(O)CH2CH3), 1.82 (s, -CH3), 1.17 (t, 6H, 3J = 7.3 Hz, P(O)CH2CH3); 13C NMR (DMSO-d6, 75.4 MHz): δ 159.64 (C-5′), 148.01 (C-2′), 145.72 (C-2), 129.2 (C-4), 120.8 (C-5), 112.79 (C-4′), 63.5 (d, 2JP-C = 7.3 Hz, P(O)CH2CH3), 44.7 (P-C), 14.6 (d, 3J = 6.1 Hz, P(O)CH2CH3), 14.1 (-CH3); 31P NMR (DMSO-d6, 121.4 MHz): δ 21.61; ESI-MS: 314.16; anal. calcd for C12H19N4O4P (314): C, 45.86; H, 6.09; N, 17.83%. Found: C, 45.84; H, 6.04; N, 17.82%.
O), 759 (P-C); 1H NMR (DMSO-d6, 500 MHz): δ 5.85 (s, 1H, NH), 7.28–7.39 (m, 3Ar-H), 5.48 (d, JP-C = 10.8 Hz, P-CH), 3.44 (d, 3JP-H= 10.5 Hz, P-OCH3), 3.69 (d, 3JP-H= 11.1 Hz, P-OCH3), 1.84 (s, -CH3); 31P NMR (DMSO-d6, 121.4 MHz): δ 22.82; ESI-MS: 286.07; anal. calcd for C10H15N4O4P (286): C, 41.96; H, 5.28; N, 19.57%. Found: C, 41.91; H, 5.26; N, 19.52%.
O), 751 (P-C); 1H NMR (DMSO-d6, 500 MHz): δ 6.81–7.01 (m, 4Ar-H), 2.82 (s, 6H), 5.54 (s, NH), 5.12 (d, JP-C = 11.2 Hz, P-CH), 3.81–4.10 (m, 4H, P(O)CH2CH3), 1.18 (t, 6H, 3J = 7.8 Hz, P(O)CH2CH3); 13C NMR (DMSO-d6, 75.4 MHz): δ 160.16 (C-5′), 153.42 (C-3′), 139.72 (C-4), 131.14 (C-2 and C-6), 128.83 (C-1), 123.58 (C-3 and C-5), 116.75 (C-4′), 63.6 (d, 2JP-C = 7.6 Hz, P(O)CH2CH3), 46.1 (P-C), 16.9 (d, 3JP-C = 5.9 Hz, P(O)CH2CH3), 14.8 (-N(CH3)2), 15.7 (-CH3); 31P NMR (DMSO-d6, 121.4 MHz): δ 20.42; ESI-MS: 367.04; anal. calcd for C17H26N3O4P (367): C, 55.58; H, 7.13; N, 11.44%. Found: C, 55.54; H, 7.08; N, 11.39%.
O), 766 (P-C); 1H NMR (DMSO-d6, 500 MHz): δ 6.75–7.93 (m, 4Ar-H), 2.85 (s, 6H), 5.49 (s, NH), 5.19 (d, JP-C = 11.2 Hz, P-CH), 3.56 (d, 3JP-H= 10.4 Hz, P-OCH3), 3.74 (d, 3JP-H= 11.1 Hz, P-OCH3); 31P NMR (DMSO-d6, 121.4 MHz): δ 22.35; ESI-MS: 339.18; anal. calcd for C15H22N3O4P (339): C, 53.09; H, 6.53; N, 12.38%. Found: C, 52.09; H, 6.48; N, 12.33%.
O), 763 (P-C); 1H NMR (DMSO-d6, 500 MHz): δ 6.58–6.72 (m, 4Ar-H), 5.61 (s, 1H, NH), 5.04 (d, 1H, 2JP-C = 11.3 Hz, P-CH), 3.72–3.98 (m, 4H, P(O)CH2CH3), 1.89 (s, 3H), 1.08 (t, 6H, 3J = 7.8 Hz, P(O)CH2CH3); 31P NMR (DMSO-d6, 121.4 MHz): δ 22.83; ESI-MS: 340.16; anal. calcd for C15H21N2O5P (340): C, 52.94; H, 6.22; N, 8.23%. Found: C, 52.90; H, 6.17; N, 8.19%.
O), 779 (P-C); 1H NMR (DMSO-d6, 500 MHz): δ 6.52–6.68 (m, 4Ar-H), 5.65 (s, 1H, NH), 4.98 (d, 1H, 2JP-C = 11.3 Hz, P-CH), 3.46 (d, 3JP-H= 10.2 Hz, P-OCH3), 3.76 (d, 3JP-H= 10.9 Hz, P-OCH3), 1.86 (s, 3H); 13C NMR (DMSO-d6, 75.4 MHz): δ 161.36 (C-5′), 151.61 (C-2′), 146.03 (C-4), 131.75 (C-1), 129.53 (C-2 and C-6), 124.91 (C-3 and C-5), 110.36 (C-4′), 54.8 (P-OCH3, d, J = 6.5 Hz), 46.5 (P-C), 14.6 (-CH3); 31P NMR (DMSO-d6, 121.4 MHz): δ 21.76; ESI-MS: 312.27; anal. calcd for C13H17N2O5P (312): C, 50.00; H, 5.49; N, 8.97%. Found: C, 49.62; H, 5.42; N, 8.91%.
O), 751 (P-C); 1H NMR (DMSO-d6, 500 MHz): δ 6.75–7.58 (m, 6H, Ar-H), 9.98 (s, 1H, Ar-NH), 5.59 (s, 1H, Aliph-NH), 4.88 (d, 1H, 2JP-C = 11.2 Hz, PCH); 3.68–3.81 (m, 4H, P(O)CH2CH3), 2.10 (s, 3H), 1.23 (t, 6H, 3J = 7.8 Hz, P(O)CH2CH3); 31P NMR (DMSO-d6, 121.4 MHz): δ 24.75; ESI-MS: 363.28; anal. calcd for C17H22N3O4P (363): C, 56.19; H, 6.10; N, 11.56%. Found: C, 56.13; H, 6.06; N, 11.51%.
O), 746 (P-CH); 1H NMR (DMSO-d6, 500 MHz): δ 6.84–7.70 (m, 6H, Ar-H), 10.12 (s, 1H, Ar-NH), 5.70 (s, 1H, Aliph-NH), 4.76–4.88 (m, 1H, PCH), 3.28 (d, 3JP-H= 10.0 Hz, P-OCH3), 3.57 (d, 3JP-H= 11.1 Hz, P-OCH3), 2.10 (s, 3H, Ar-CH3); 13C NMR (DMSO-d6, 75.4 MHz): δ 122.7 (C-2), 112.5 (C-3), 121.8 (C-4), 120.6 (C-5), 119.6 (C-6), 111.5 (C-7), 131.2 (C-8), 179 (C-9), 151.5 (C-3′), 113.5 (C-4′), 160.9 (C-5′), 54.76 (P-CH), 53.9 (P-OCH3, d, J = 6.5 Hz), 15.8 (Ar-CH3); 31P NMR (DMSO-d6, 121.4 MHz); δ 31.29; ESI-MS: 315.11; anal. calcd for C15H18N3O4P (315): C, 53.73; H, 5.41; N, 12.53%. Found: C, 53.53; H, 5.31; N, 12.50%.
O), 749 (P-C); 1H NMR (DMSO-d6, 500 MHz): δ 6.48–6.92 (m, 5Ar-H), 6.12 (s, oxazole H), 5.62 (brs, NH), 4.56 (d, JP-C = 7.2 Hz, P–CH), 3.67–4.07 (m, 4H, P(O)CH2CH3), 2.16–2.54 (m, 2H), 1.87 (t, 3JC-H = 7.0 Hz, 2H), 1.28 (t, 3JH-H = 7.0 Hz, 6H, P(O)CH2CH3);31P NMR (DMSO-d6, 121.4 MHz): δ 21.35; ESI-MS: 352; anal. calcd for C17H25N2O4P (352): C, 57.95; H, 7.15; N, 7.95%. Found: C, 57.91; H, 7.10; N, 7.91%.
O), 732 (P-C); 1H NMR (DMSO-d6, 500 MHz): δ 6.44 (s, oxazole H), 5.17 (brs, NH), 4.34 (d, JP-C = 7.2 Hz, P-CH), 3.55–3.85 (m, 4H, P(O)CH2CH3), 2.31–2.48 (m, 1H), 1.28 (t, 3JH-H = 7.0 Hz, 6H, P(O)CH2CH3), 1.08 (m, 6H); 31P NMR (DMSO-d6, 121.4 MHz): δ 17.68; ESI-MS: 290; anal. calcd for C12H23N2O4P (290): C, 49.65; H, 7.99; N, 9.65%. Found: C, 49.59; H, 7.95; N, 9.60%.
O, phosphonate), 1009 (P-O-C); 1H-NMR (CDCl3, 500 MHz): δ 7.63–7.79 (m, 4Ar-H), 5.23 (d, 2JP-H = 10.2 Hz, P-C-H), 3.93–4.08 (m, 4H, P(O)CH2CH3), 1.185 (t, 3JH-H = 7.2 Hz, 6H, P(O)CH2CH3); 13C-NMR (CDCl3, 75.4 MHz): δ 147.47 (C-3), 141.13 (C-1), 133.86 (C-6), 129.37 (C-5), 122.36 (C-2), 121.72 (C-4), 69.05 (P–C), 52.59 (d, 2JP-C = 7.6 Hz, P-OCH2CH3), 18.53 (d, 3JP-C = 5.8 Hz, P-OCH2-CH3); 31P-NMR (CDCl3, 121.4 MHz): δ 21.61 (P
O); ESI-MS: 289.09; anal. calcd for C11H16NO6P (289): C, 45.68; H, 5.58%. Found: C, 45.65; H, 5.54%.
O), 1065 (P-O-C); 1H-NMR (CDCl3, 500 MHz): δ 7.09–7.17 (m, 4Ar-H), 4.69 (d, 2JP-H = 10.2 Hz, P-C-H), 3.86–4.12 (m, 4H, P(O)CH2CH3), 1.18 (t, 3JH-H = 7.0 Hz, 6H, P(O)CH2CH3); 13C-NMR (CDCl3, 75.4 MHz): δ 148.5 (C-4), 139.23 (C-1), 129.36 (C-2), 128.42 (C-6), 121.73 (C-3), 121.54 (C-5), 73.4 (P-C), 56.9 (d, 2JP-C = 7.5 Hz, P-OCH2CH3), 17.8 (d, 3JP-C = 5.8 Hz, P-OCH2-CH3); 31P-NMR (CDCl3, 121.4 MHz): δ 21.52 (P
O); ESI-MS: 262.14; anal. calcd for C11H16O4PF (262): C, 50.39; H, 6.15%. Found: C, 50.35; H, 6.10%.
O, phosphonate), 1026 (P-O-C); 1H-NMR (CDCl3, 500 MHz): δ 9.38 (s, 1H, imidazole NH), 7.32–7.39 (m, 2Ar-H), 5.12 (d, 2JP-H = 10.3 Hz, P-C-H), 3.52–3.78 (m, 4H, P(O)CH2CH3), 1.23 (t, 3JH-H = 7.3 Hz, 6H, P(O)CH2CH3); 13C-NMR (CDCl3, 75.4 MHz): δ 149.3 (C-1), 125.2 (C-3), 124.6 (C-4), 72.8 (P-C), 60.1 (d, 2JP-C = 7.6 Hz, P-OCH2CH3), 15.6 (d, 3JP-C = 5.7 Hz, P-OCH2-CH3); 31P-NMR (CDCl3, 121.4 MHz): δ 21.72 (P
O); ESI-MS: 235.21; anal. calcd for C8H16N2O4P (235): C, 40.85; H, 6.86%. Found: C, 40.82; H, 6.81%.
O, phosphonate), 1005 (P-O-C); 1H-NMR (CDCl3, 500 MHz): δ 9.94 (s, 1H, indole NH), 7.02–8.66 (m, 5Ar-H), 4.76 (d, 2JP-H = 10.2 Hz, P-C-H), 3.61–3.77 (m, 4H, P(O)CH2CH3), 1.18 (t, 3JH-H = 7.3 Hz, 6H, P(O)CH2CH3); 13C-NMR (CDCl3, 75.4 MHz): δ 138.36 (C-4), 135.52 (C-9), 121.06 (C-2), 120.64 (C-6), 119.04 (C-7), 117.35 (C-8), 116.38 (C-1), 115.15 (C-5), 76.26 (P-C), 59.96 (d, 2JP-C = 7.6 Hz, P-OCH2CH3), 16.12 (d, 3JP-C = 5.8 Hz, P-OCH2-CH3); 31P-NMR (CDCl3, 121.4 MHz): δ 20.69 (P
O); ESI-MS: 283.18; anal. calcd for C13H18NO4P (283): C, 55.12; H, 6.41%. Found: C, 55.09; H, 6.38%.
O, phosphonate), 1011 (P-O-C); 1H-NMR (CDCl3, 500 MHz): δ 7.13–8.09 (m, 3Ar-H), 5.06 (s, 2H), 4.94 (d, 2JP-H = 10.0 Hz, P-C-H), 3.92–4.09 (m, 4H, P(O)CH2CH3), 1.27 (t, 3JH-H = 7.2 Hz, 6H, P(O)CH2CH3); 13C-NMR (CDCl3, 75.4 MHz): δ 158.8 (C-6), 128.7 (C-2), 128.6 (C-4), 128.0 (C-1), 125.3 (C-3), 124.1 (C-5), 76.1 (P-C), 63.0 (d, 2JP-C = 7.5 Hz, P-OCH2CH3), 16.3 (d, 3JP-C = 5.7 Hz, P-OCH2-CH3); 31P-NMR (CDCl3, 121.4 MHz): δ 22.57 (P
O); ESI-MS: 313.05; anal. calcd for C11H15O4PCl2 (313): C, 42.19; H, 4.83%. Found: C, 42.14; H, 4.81%.
O, phosphonate), 1028 (P-O-C); 1H-NMR (CDCl3, 500 MHz): δ 6.84–7.17 (m, 4Ar-H), 4.74 (d, 2JP-H = 10.2 Hz, P-C-H), 3.87–4.16 (m, 4H, P(O)CH2CH3), 1.33 (t, 3JH-H = 7.0 Hz, 6H, P(O)CH2CH3); 31P-NMR (CDCl3, 121.4 MHz): δ 23.71 (P
O); ESI-MS: 278.19; anal. calcd for C11H16O4PCl (278): C, 47.41; H, 5.79%. Found: C, 47.37; H, 5.74%.
O, phosphonate), 1025 (P-O-C); 1H-NMR (CDCl3, 500 MHz): δ 6.56–6.94 (m, 4Ar-H), 4.80 (d, 2JP-H = 10.4 Hz, P-C-H), 3.65–3.84 (m, 4H, P(O)CH2CH3), 1.13 (t, 3JH-H = 7.2 Hz, 6H, P(O)CH2CH3); 31P-NMR (CDCl3, 121.4 MHz): δ 22.63 (P
O); ESI-MS: 260.04; anal. calcd for C11H17O5P (260): C, 50.77; H, 6.58%. Found: C, 50.72; H, 6.51%.
O, phosphonate), 1042 (P-O-C); 1H NMR (CDCl3, 500 MHz): δ 7.19–7.38 (m, 4Ar-H), 4.94 (d, 2JP-H = 10.4 Hz, 1H), 3.92–4.08 (m, 4H, P(O)CH2CH3), 2.85–2.92 (m, 1H), 1.17–1.26 (m, 6H), 1.165 (t, 3JH-H = 7.2 Hz, 6H, P(O)CH2CH3); 31P NMR (CDCl3, 121.4 MHz): δ 22.83 (P
O); ESI-MS: 286.15; anal. calcd for C14H23O4P (286): C, 58.73; H, 8.10%. Found: C, 58.69; H, 8.07%.
O, phosphonate), 1061 (P-O-C); 1H-NMR (CDCl3, 500 MHz): δ 6.87–7.01 (m, 4Ar-H), 5.18 (d, 2JP-H = 10.3 Hz, P-C-H), 4.02–4.29 (m, 4H, P(O)CH2CH3), 1.19 (t, 3J = 7.3 Hz, 6H, P(O)CH2CH3), 2.82 (s, 6H); 31P-NMR (CDCl3, 121.4 MHz): δ 21.40 (P
O); ESI-MS: 287.21; anal. calcd for C13H22NO4P (287): C, 54.35; H, 7.72%. Found: C, 54.31; H, 7.69%.
O, phosphonate), 1032 (P-O-C); 1H-NMR (CDCl3, 500 MHz): δ 6.78–7.07 (m, 4Ar-H), 4.87 (d, 2JP-H = 10.2 Hz, P-C-H), 3.90–4.19 (m, 4H, P(O)CH2CH3), 3.86 (s, 3H), 3.57 (s, 3H), 1.28 (t, 3J = 7.2 Hz, 6H, P(O)CH2CH3); 31P-NMR (CDCl3, 121.4 MHz): δ 22.20 (P
O); ESI-MS: 304.08; anal. calcd for C13H21O6P (304): C 51.31, H 6.96%. Found: C 51.29, H 6.92%.
| This journal is © The Royal Society of Chemistry 2011 |